The role of tight junctions in cancer metastasis

Seminars in Cell and Developmental Biology

Volumn 36, Issue , 2014, Pages 224-231

  Martin, Tracey A ^a  

^a CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Metastasis; Tight junction; Tumour

Indexed keywords

TIGHT JUNCTION PROTEIN;

BLOOD BRAIN BARRIER; BLOOD VESSEL PERMEABILITY; BREAST METASTASIS; CANCER GROWTH; CELL ADHESION; CELL INVASION; CELL MEMBRANE; ELECTRON MICROSCOPY; HUMAN; MELANOMA; MESOTHELIUM; METASTASIS; OSTEOBLAST; PROSTATE EPITHELIUM; PROTEIN EXPRESSION; REVIEW; SMALL CELL LUNG CANCER; TIGHT JUNCTION; TUMOR MICROENVIRONMENT; VASCULAR ENDOTHELIUM;

EID: 84912530586     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2014.09.008     Document Type: Review

References (64)

1. Coghlin C., Murray G.I. Current and emerging concepts in tumour metastasis. J Pathol 2010, 222(1):1-15. 10.1002/path.2727.
2. Furuse M., Fujita K., Hiiragi T., Fujimoto K., Tsukita S. Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J Cell Biol 1998, 141(7):1539-1550. 10.1083/jcb.141.7.1539.
3. Van Itallie C.M., Anderson J.M. Architecture of tight junctions and principles of molecular composition. Semin Cell Dev Biol 2014, pii: S1084-9521(14)00251-1. 10.1016/j.semcdb.08.011.
4. Shen L., Weber C.R., Raleigh D.R., Yu D., Turner J.R. Tight junction pore and leak pathways: a dynamic duo. Annu Rev Physiol 2011, 73:283-309. 10.1146/annurev-physiol-012110-142150.
5. Fanning A.S., Mitic L.L., Anderson J.M. Transmembrane proteins in the tight junction barrier. J Am Soc Nephrol 1999, 10(6):1337-1345. [PMid: 10361874].
6. Chlenski A., Ketels K.V., Tsao M.S., Talamonti M.S., Anderson M.R., Oyasu R., et al. Tight junction protein ZO-2 is differentially expressed in normal pancreatic ducts compared to human pancreatic adenocarcinoma. Int J Cancer 1999, 82(1):37-44. 10.1002/(SICI)1097.
7. Shin K., Fogg V.C., Margolis B. Tight junctions and cell polarity. Annu Rev Cell Dev Biol 2006, 22:207-235. 10.1146/annurev.cellbio.22.010305.104219.
8. Latorre I.J., Roh M.H., Frese K.K., Weiss R.S., Margolis B., Javier R.T. Viral oncoprotein-induced mislocalization of select PDZ proteins disrupts tight junctions and causes polarity defects in epithelial cells. J Cell Sci 2005, 118(Pt 18):4283-4293. 10.1242/jcs.02560.
9. Devita V.T., Young R.C., Canellos G.P. Combination versus single agent chemotherapy, a review of the basis for selection of drug treatment of cancer. Cancer 1975, 35:98-110.
10. Brooks P.C. Cell adhesion molecules in angiogenesis. Can Met Rev 1996, 15:187-194.
11. Folkman J., Shing Y. Angiogenesis. J Biol Chem 1992, 267:10931-10934.
12. Folkman J. Fighting cancer by attacking its blood supply. Sci Am 1996, 275:150-151.
13. Ono M., Torisu H., Fukushi H.J., Nishie A., Kuwana M. Biological implications of macrophage infiltration in human tumor angiogenesis. Can Chem Pharm 1999, 43:S69-S71.
14. Martin T.A., Jiang W.G. Loss of tight junction barrier function and its role in cancer metastasis. Biochim Biophys Acta 2009, 1788(4):872-891. 10.1016/j.bbamem.2008.
15. Martin T.A., Mansel R.E., Jiang W.G. Antagonistic effect of NK4 on HGF/SF induced changes in the transendothelial resistance (TER) and paracellular permeability of human vascular endothelial cells. J Cell Physiol 2002, 192(3):268-275. 10.1002/jcp.10133.
16. Hoevel T., Macek R., Mundigl O., Swisshelm K., Kubbies M. Expression and targeting of the tight junction protein CLDN1 in CLDN1-negative human breast tumor cells. J Cell Physiol 2002, 191(1):60-68. 10.1002/jcp.10076.
17. Ren J., Hamada J., Takeichi N., Fujikawa S., Kobayashi H. Ultrastructural differences in junctional intercellular communication between highly and weakly metastatic clones derived from rat mammary carcinoma. Cancer Res 1990, 50(2):358-362. [PMid: 2295075].
18. Satoh H., Zhong Y., Isomura H., Saitoh M., Enomoto K., Sawada N., et al. Localization of 7H6 tight junction-associated antigen along the cell border of vascular endothelial cells correlates with paracellular barrier function against ions, large molecules, and cancer cells. Exp Cell Res 1996, 222(2):269-274. 10.1006/excr.1996.0034.
19. Martinez-Paloma A. Ultrastructural modifications of intercellular junctions in some epithelial tumors. Lab Invest 1970, 22(6):9.
20. Inoue T., Shimono M., Yamamura T., Saito I., Watanabe O., Kawahara H. Acinic cell carcinoma arising in the glossopalatine glands: a report of two cases with electron microscopic observations. Oral Surg Oral Med Oral Pathol 1984, 57(4):398-407. 10.1016/0030-4220(84)90159-2.
21. Mullin J.M., O'Brien T.G. Effects of tumor promoters on LLC-PK1 renal epithelial tight junctions and transepithelial fluxes. Am J Physiol 1986, 251(4 (Pt 1)):C597-C602.
22. Gopalakrishnan S., Raman N., Atkinson S.J., Marrs J.A. Rho GTPase signaling regulates tight junction assembly and protects tight junctions during ATP depletion. Am J Physiol 1998, 275(3 (Pt 1)):C798-C809.
23. Hart I.R., Goode N.T., Wilson R.E. Molecular aspects of the metastatic cascade. Biochim Biophys Acta 1989, 989(1):65-84. [PMid: 2665818].
24. Jiang W.G., Puntis M.C., Hallett M.B. Molecular and cellular basis of cancer invasion and metastasis: implications for treatment. Br J Surg 1994, 81(11):1576-1590. 10.1002/bjs.1800811107.
25. Utoguchi N., Mizuguchi H., Dantakean A., Makimoto H., Wakai Y., Tsutsumi Y., et al. Effect of tumour cell-conditioned medium on endothelial macromolecular permeability and its correlation with collagen. Br J Cancer 1996, 73(1):24-28. [PMid: 8554978].
26. Jiang W.G., Martin T.A., Matsumoto K., Nakamura T., Mansel R.E. Hepatocyte growth factor/scatter factor decreases the expression of occludin and transendothelial resistance (TER) and increases paracellular permeability in human vascular endothelial cells. J Cell Physiol 1999, 181(2):319-329. 10.1002/(SICI)1097-4652(199911)181:2<319::AID-JCP14>3.0.CO;2-S.
27. Clark P.R., Manes T.D., Pober J.S., Kluger M.S. Increased ICAM-1 expression causes endothelial cell leakiness, cytoskeletal reorganization and junctional alterations. J Invest Dermatol 2007, 127(4):762-774. 10.1038/sj.jid.5700670.
28. Rajashekhar G., Shivanna M., Kompella U.B., Wang Y., Srinivas S.P. Role of MMP-9 in the breakdown of barrier integrity of the corneal endothelium in response to TNF-alpha. Exp Eye Res 2014, 122:77-85. 10.1016/j.exer.2014.03.004.
29. Zhou W., Fong M.Y., Min Y., Somlo G., Liu L., Palomares M.R., et al. Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis. Cancer Cell 2014, 25(4):501-515. 10.1016/j.ccr.2014.03.007.
30. Yang Z.H., Liu L.B., Zhao L.N., Liu Y.H., Xue Y.X. Permeability of the blood-tumor barrier is enhanced by combining vascular endothelial growth factor with papaverine. J Neurosci Res 2014, 92(6):703-713. 10.1002/jnr.23348.
31. Ma J., Wang P., Liu Y., Zhao L., Li Z., Xue Y. Krüppel-like factor 4 regulates blood-tumor barrier permeability via ZO-1, occludin and claudin-5. J Cell Physiol 2014, 229(7):916-926. 10.1002/jcp.24523.
32. Baker M., Reynolds L.E., Robinson S.D., Lees D.M., Parsons M., Elia G., et al. Stromal Claudin 14-heterozygosity, but not deletion, increases tumour blood leakage without affecting tumour growth. PLOS ONE 2013, 8(5):e62516. 10.1371/journal.pone.0062516.
33. Herr D., Sallmann A., Bekes I., Konrad R., Holzheu I., Kreienberg R., et al. VEGF induces ascites in ovarian cancer patients via increasing peritoneal permeability by downregulation of Claudin 5. Gynecol Oncol 2012, 127(1):210-216. 10.1016/j.ygyno.2012.05.002.
34. Kominsky S.L., Argani P., Korz D., Evron E., Raman V., Garrett E., et al. Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene 2003, 22(13):2021-2033. 10.1038/sj.onc.1206199.
35. Tobioka H., Sawada N., Zhong Y., Mori M. Enhanced paracellular barrier function of rat mesothelial cells partially protects against cancer cell penetration. Br J Cancer 1996, 74(3):439-445.
36. Slattum G.M., Jody R. Tumour cell invasion: an emerging role for basal epithelial cell extrusion. Nat Rev Can 2014, 14:495-501. 10.1038/nrc3767.
37. Stucke V.M., Timmerman E., Vandekerckhove J., Gevaert J.K., Hall A. The MAGUK protein MPP7 binds to the polarity protein hDlg1 and facilitates epithelial tight junction formation. Mol Biol Cell 2007, 18(5):1744-1755. 10.1091/mbc.E06-11-0980.
38. Mullin J.M., Leatherman J.M., Valenzano M.C., Huerta E.R., Verrechio J., Smith D.M., et al. Ras mutation impairs epithelial barrier function to a wide range of nonelectrolytes. Mol Biol Cell 2005, 16(12):5538-5550. 10.1091/mbc.E05-04-0294.
39. Soler A.P., Miller R.D., Laughlin K.V., Carp N.Z., Klurfeld D.M., Mullin J.M. Increased tight junctional permeability is associated with the development of colon cancer. Carcinogenesis 1999, 20(8):1425-1431. 10.1093/carcin/20.8.1425.
40. Mullin J.M., Laughlin K.V., Ginanni N., Marano W., Clarke H.M., Peralta Soler A. Increased tight junction permeability can result from protein kinase C activation/translocation and act as a tumor promotional event in epithelial cancers. Ann N Y Acad Sci 2000, 915:231-236. [PMid: 11193580].
41. Clarke H., Soler A.P., Mullin J.M. Protein kinase C activation leads to dephosphorylation of occludin and tight junction permeability increase in LLC-PK1 epithelial cell sheets. J Cell Sci 2000, 113(Pt 18):3187-3196. [PMid: 10954417].
42. Martin T.A., Watkins G., Mansel R.E., Jiang W.G. Hepatocyte growth factor disrupts tight junctions in human breast cancer cells. Cell Biol Int 2004, 28(5):361-371. 10.1016/j.cellbi.2004.03.003.
43. Macias C.L., Williams K., Baccetti B., Renieri T., Reddi H., Asseffa A., et al. Culture and co-culture of DU145 prostate carcinoma, osteoblasts and HT-29 colon carcinoma cells on a fabricated type III collagen matrix. J Submicrosc Cytol Pathol 2002, 34(3):241-253.
44. Alshbool F.Z., Mohan S. Emerging multifunctional roles of Claudin tight junction proteins in bone. Endocrinology 2014, 155(7):2363-2376. 10.1210/en.2014-1173.
45. Logothetis C.J., Lin S.H. Osteoblasts in prostate cancer metastasis to bone. Nat Rev Can 2005, 5:21-28. 10.1038/nrc1528.
46. Chen Y.C., Sosnoski D.M., Mastro A.M. Breast cancer metastasis to the bone: mechanisms of bone loss. Breast Cancer Res 2010, 12:215. 10.1186/bcr2781.
47. Soini Y. Claudins 2, 3, 4, and 5 in Paget's disease and breast carcinoma. Hum Pathol 2004, 35(12):1531-1536.
48. Long H., Crean C.D., Lee W.H., Cummings O.W., Gabig T.G. Expression of Clostridium perfringens enterotoxin receptors claudin-3 and claudin-4 in prostate cancer epithelium. Cancer Res 2001, 61(21):7878-7881. [PMid: 11691807].
49. Jia W., Martin T.A., Zhang G., Jiang W.G. Junctional adhesion molecules in cerebral endothelial tight junction and brain metastasis. Anticancer Res 2013, 33(6):2353-2359.
50. Greig N.H., Jones H.B., Cavanagh J.B. Blood-brain barrier integrity and host responses in experimental metastatic brain tumours. Clin Exp Metastasis 1983, 1(3):229-246.
51. Fenner M.H., Possinger K. Chemotherapy for breast cancer brain metastases. Onkologie 2002, 25(5):474-479.
52. Seelbach M., Chen L., Powell A., Choi Y.J., Zhang B., Hennig B., et al. Polychlorinated biphenyls disrupt blood-brain barrier integrity and promote brain metastasis formation. Environ Health Perspect 2010, 118(4):479-484. 10.1289/ehp.0901334.
53. Sevenich L., Bowman R.L., Mason S.D., Quail D.F., Rapaport F., Elie B.T., et al. Analysis of tumour- and stroma-supplied proteolytic networks reveals a brain-metastasis-promoting role for cathepsin S. Nat Cell Biol 2014, 10.1038/ncb3011.
54. Fazakas C., Wilhelm I., Nagyoszi P., Farkas A.E., Haskó J., Molnár J., et al. Transmigration of melanoma cells through the blood-brain barrier: role of endothelial tight junctions and melanoma-released serine proteases. PLoS ONE 2011, 6(6):e20758. 10.1371/journal.pone.0020758.
55. Feng S., Cen J., Huang Y., Shen H., Yao L., Wang Y., et al. Matrix metalloproteinase-2 and -9 secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight junction proteins. PLoS ONE 2011, 6(8):e20599. 10.1371/journal.pone.0020599.
56. Li B., Wang C., Zhang Y., Zhao X.Y., Huang B., Wu P.F., et al. Elevated PLGF contributes to small-cell lung cancer brain metastasis. Oncogene 2013, 32(24):2952-2962. 10.1038/onc.2012.313.
57. Hensley P.J., Desiniotis A., Wang C., Stromberg A., Chen C.S., Kyprianou N. Novel pharmacologic targeting of tight junctions and focal adhesions in prostate cancer cells. PLOS ONE 2014, 9(1):e86238. 10.1371/journal.pone.0086238.
58. Avraham H.K., Jiang S., Fu Y., Nakshatri H., Ovadia H., Avraham S. Angiopoietin-2 mediates blood-brain barrier impairment and colonization of triple-negative breast cancer cells in brain. J Pathol 2014, 232(3):369-381. 10.1002/path.4304.
59. Thompson E.M., Pishko G.L., Muldoon L.L., Neuwelt E.A. Inhibition of SUR1 decreases the vascular permeability of cerebral metastases. Neoplasia 2013, 15(5):535-543.
60. Kim S.O., Choi Y.H. The ethyl alcohol extract of Hizikia fusiforme inhibits matrix metalloproteinase activity and regulates tight junction related protein expression in Hep3B human hepatocarcinoma cells. J Med Food 2010, 13(1):31-38. 10.1089/jmf.2009.1233.
61. Shah G.V., Muralidharan A., Thomas S., Gokulgandhi M., Mudit M., Khanfar M., et al. Identification of a small molecule class to enhance cell-cell adhesion and attenuate prostate tumor growth and metastasis. Mol Cancer Ther 2009, 8(3):509-520. 10.1158/1535-7163.MCT-08-0693.
62. Rodriguez P.L., Jiang S., Fu Y., Avraham S., Avraham H.K. The proinflammatory peptide substance P promotes blood-brain barrier breaching by breast cancer cells through changes in microvascular endothelial cell tight junctions. Int J Cancer 2014, 134(5):1034-1044. 10.1002/ijc.28433.
63. Kakutani H., Kondoh M., Saeki R., Fujii M., Watanabe Y., Mizuguchi H., et al. Claudin-4-targeting of diphtheria toxin fragment A using a C-terminal fragment of Clostridium perfringens enterotoxin. Eur J Pharm Biopharm 2010, 5(2):213-217. 10.1016/j.ejpb.2010.03.003.
64. Ishida M., Kushima R., Okabe H. Claudin expression in rectal well-differentiated endocrine neoplasms (carcinoid tumors). Oncol Rep 2009, 21(1):113-117. [PMid: 19082451].